Tham khảo Atrasentan

  1. ↑ “Atrasentan”. NCI Dictionary of Cancer Terms. National Institute of Cancer. 
  2. ↑ Chiappori, Alberto A.; Haura, Eric; Rodriguez, Francisco A.; Boulware, David; Kapoor, Rachna; Neuger, Anthony M.; Lush, Richard; Padilla, Barbara; Burton, Michelle; Williams, Charles; Simon, George; Antonia, Scott; Sullivan, Daniel M.; Bepler, Gerold (tháng 3 năm 2008). “Phase I/II Study of Atrasentan, an Endothelin A Receptor Antagonist, in Combination with Paclitaxel and Carboplatin as First-Line Therapy in Advanced Non–Small Cell Lung Cancer”. Clinical Cancer Research 14 (5): 1464–9. PMID 18316570. doi:10.1158/1078-0432.CCR-07-1508. 
  3. ↑ “Addition of experimental drug to standard chemotherapy for advanced prostate cancer shows no benefit in phase 3 clinical trial” (Thông cáo báo chí). National Cancer Institute. Ngày 21 tháng 4 năm 2011. Truy cập ngày 18 tháng 10 năm 2014. 
  4. ↑ Quinn, David I; Tangen, Catherine M; Hussain, Maha; Lara, Primo N; Goldkorn, Amir; Moinpour, Carol M; Garzotto, Mark G; Mack, Philip C; Carducci, Michael A; Monk, J Paul; Twardowski, Przemyslaw W; Van Veldhuizen, Peter J; Agarwal, Neeraj; Higano, Celestia S; Vogelzang, Nicholas J; Thompson, Ian M (tháng 8 năm 2013). “Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): a randomised phase 3 trial”. The Lancet Oncology 14 (9): 893–900. PMC 4277263. PMID 23871417. doi:10.1016/S1470-2045(13)70294-8. 
  5. ↑ de Zeeuw, Dick; Coll, Blai; Andress, Dennis; Brennan, John J.; Tang, Hui; Houser, Mark; Correa-Rotter, Ricardo; Kohan, Donald; Lambers Heerspink, Hiddo J.; Makino, Hirofumi; Perkovic, Vlado; Pritchett, Yili; Remuzzi, Giuseppe; Tobe, Sheldon W.; Toto, Robert; Viberti, Giancarlo; Parving, Hans-Henrik (tháng 5 năm 2014). “The endothelin antagonist atrasentan lowers residual albuminuria in patients with type 2 diabetic nephropathy”. Journal of the American Society of Nephrology 25 (5): 1083–93. PMC 4005314. PMID 24722445. doi:10.1681/ASN.2013080830. 
  6. ↑ Clinical trial number NCT01858532 for "Study Of Diabetic Nephropathy With Atrasentan (SONAR)" at ClinicalTrials.gov

Tài liệu tham khảo

WikiPedia: Atrasentan http://www.chemspider.com/Chemical-Structure.14032... http://www.cancer.gov/dictionary?CdrID=45029 http://www.cancer.gov/newscenter/newsfromnci/2011/... //www.ncbi.nlm.nih.gov/pmc/articles/PMC4005314 //www.ncbi.nlm.nih.gov/pmc/articles/PMC4277263 //www.ncbi.nlm.nih.gov/pubmed/18316570 //www.ncbi.nlm.nih.gov/pubmed/23871417 //www.ncbi.nlm.nih.gov/pubmed/24722445 http://www.commonchemistry.org/ChemicalDetail.aspx... //dx.doi.org/10.1016%2FS1470-2045(13)70294-8